These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 36091042)

  • 21. Endothelial Zeb2 preserves the hepatic angioarchitecture and protects against liver fibrosis.
    de Haan W; Dheedene W; Apelt K; Décombas-Deschamps S; Vinckier S; Verhulst S; Conidi A; Deffieux T; Staring MW; Vandervoort P; Caluwé E; Lox M; Mannaerts I; Takagi T; Jaekers J; Berx G; Haigh J; Topal B; Zwijsen A; Higashi Y; van Grunsven LA; van IJcken WFJ; Mulugeta E; Tanter M; Lebrin FPG; Huylebroeck D; Luttun A
    Cardiovasc Res; 2022 Mar; 118(5):1262-1275. PubMed ID: 33909875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of XBP1 in regulating the progression of non-alcoholic steatohepatitis.
    Wang Q; Zhou H; Bu Q; Wei S; Li L; Zhou J; Zhou S; Su W; Liu M; Liu Z; Wang M; Lu L
    J Hepatol; 2022 Aug; 77(2):312-325. PubMed ID: 35292349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycogen synthase kinase 3 activity enhances liver inflammation in MASH.
    Khoury M; Guo Q; Furuta K; Correia C; Meroueh C; Kim Lee HS; Warasnhe K; Valenzuela-Pérez L; Mazar AP; Kim I; Noh YK; Holmes H; Romero MF; Sussman CR; Pavelko KD; Islam S; Bamidele AO; Hirsova P; Li H; Ibrahim SH
    JHEP Rep; 2024 Jun; 6(6):101073. PubMed ID: 38882600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New aspects of hepatic endothelial cells in physiology and nonalcoholic fatty liver disease.
    Sun X; Harris EN
    Am J Physiol Cell Physiol; 2020 Jun; 318(6):C1200-C1213. PubMed ID: 32374676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single-Cell Transcriptomics Reveals Zone-Specific Alterations of Liver Sinusoidal Endothelial Cells in Cirrhosis.
    Su T; Yang Y; Lai S; Jeong J; Jung Y; McConnell M; Utsumi T; Iwakiri Y
    Cell Mol Gastroenterol Hepatol; 2021; 11(4):1139-1161. PubMed ID: 33340713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteopontin is a proximal effector of leptin-mediated non-alcoholic steatohepatitis (NASH) fibrosis.
    Coombes JD; Choi SS; Swiderska-Syn M; Manka P; Reid DT; Palma E; Briones-Orta MA; Xie G; Younis R; Kitamura N; Della Peruta M; Bitencourt S; Dollé L; Oo YH; Mi Z; Kuo PC; Williams R; Chokshi S; Canbay A; Claridge LC; Eksteen B; Diehl AM; Syn WK
    Biochim Biophys Acta; 2016 Jan; 1862(1):135-44. PubMed ID: 26529285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibromodulin, an oxidative stress-sensitive proteoglycan, regulates the fibrogenic response to liver injury in mice.
    Mormone E; Lu Y; Ge X; Fiel MI; Nieto N
    Gastroenterology; 2012 Mar; 142(3):612-621.e5. PubMed ID: 22138190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The endothelial dysfunction blocker CU06-1004 ameliorates choline-deficient L-amino acid diet-induced non-alcoholic steatohepatitis in mice.
    Bae CR; Zhang H; Kwon YG
    PLoS One; 2020; 15(12):e0243497. PubMed ID: 33275637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Restoration of Sinusoid Fenestrae Followed by Targeted Nanoassembly Delivery of an Anti-Fibrotic Agent Improves Treatment Efficacy in Liver Fibrosis.
    Li F; Zhao Y; Cheng Z; Wang Y; Yue Y; Cheng X; Sun J; Atabakhshi-Kashi M; Yao J; Dou J; Yu J; Zhang X; Qi Y; Li X; Qi X; Nie G
    Adv Mater; 2023 Apr; 35(17):e2212206. PubMed ID: 36862807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sinusoidal endotheliopathy in nonalcoholic steatohepatitis: therapeutic implications.
    Ibrahim SH
    Am J Physiol Gastrointest Liver Physiol; 2021 Jul; 321(1):G67-G74. PubMed ID: 34037463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunonano-Lipocarrier-Mediated Liver Sinusoidal Endothelial Cell-Specific RUNX1 Inhibition Impedes Immune Cell Infiltration and Hepatic Inflammation in Murine Model of NASH.
    Tripathi DM; Rohilla S; Kaur I; Siddiqui H; Rawal P; Juneja P; Kumar V; Kumari A; Naidu VGM; Ramakrishna S; Banerjee S; Puria R; Sarin SK; Kaur S
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target.
    Tutusaus A; de Gregorio E; Cucarull B; Cristóbal H; Aresté C; Graupera I; Coll M; Colell A; Gausdal G; Lorens JB; García de Frutos P; Morales A; Marí M
    Cell Mol Gastroenterol Hepatol; 2020; 9(3):349-368. PubMed ID: 31689560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitronectin deficiency attenuates hepatic fibrosis in a non-alcoholic steatohepatitis-induced mouse model.
    Hayashida M; Hashimoto K; Ishikawa T; Miyamoto Y
    Int J Exp Pathol; 2019 Apr; 100(2):72-82. PubMed ID: 30887659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis C virus core protein induces dysfunction of liver sinusoidal endothelial cell by down-regulation of silent information regulator 1.
    Sun LJ; Yu JW; Shi YG; Zhang XY; Shu MN; Chen MY
    J Med Virol; 2018 May; 90(5):926-935. PubMed ID: 29350417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone Morphogenetic Protein 9 Is a Paracrine Factor Controlling Liver Sinusoidal Endothelial Cell Fenestration and Protecting Against Hepatic Fibrosis.
    Desroches-Castan A; Tillet E; Ricard N; Ouarné M; Mallet C; Belmudes L; Couté Y; Boillot O; Scoazec JY; Bailly S; Feige JJ
    Hepatology; 2019 Oct; 70(4):1392-1408. PubMed ID: 30964206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single-cell transcriptome reveals a novel mechanism of C-Kit
    Li HY; Gao YX; Wu JC; Li JZ; Fu SW; Xu MY
    Cell Biosci; 2024 Mar; 14(1):31. PubMed ID: 38461242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of the Role of Stellate Cell VCAM-1 in NASH Models in Mice.
    Chung KJ; Legaki AI; Papadopoulos G; Gercken B; Gebler J; Schwabe RF; Chavakis T; Chatzigeorgiou A
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of liver sinusoidal endothelial cells in non-alcoholic fatty liver disease.
    Hammoutene A; Rautou PE
    J Hepatol; 2019 Jun; 70(6):1278-1291. PubMed ID: 30797053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imaging Fibrogenesis in a Diet-Induced Model of Nonalcoholic Steatohepatitis (NASH).
    Hartimath SV; Boominathan R; Soh V; Cheng P; Deng X; Chong YC; Yong FF; Tan PW; Han W; Robins EG; Goggi JL
    Contrast Media Mol Imaging; 2019; 2019():6298128. PubMed ID: 31866798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endothelial TAZ inhibits capillarization of liver sinusoidal endothelium and damage-induced liver fibrosis
    Hwang JH; Heo W; Park JI; Kim KM; Oh HT; Yoo GD; Park J; Shin S; Do Y; Jeong MG; Hwang ES; Hong JH
    Theranostics; 2023; 13(12):4182-4196. PubMed ID: 37554269
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.